Our People

Sarah joined Oriel STAT A MATRIX in 2015. Since that time, she has worked with a wide range of clients to help them achieve their global RA/QA objectives. With a focus on supporting manufacturers to develop sound strategies for bringing products to market as well as strengthening ongoing compliance initiatives, Sarah takes a client-focused approach to ensure the needs of all stakeholders are accurately captured. As SVP of Business Development, Sarah provides leadership to the business development team. In this capacity, she ensures that the team provides best-in-class support to Oriel STAT A MATRIX’s clients as the global RA/QA environment continually evolves.

Sarah holds a Bachelor of Science degree with a triple major (Molecular Biology, Microbiology, Genetics) from Monash University and an MBA from Texas State University. Sarah has almost 20 years of experience ranging from laboratory science and R&D to tertiary education and professional services sales.

William (Bill) Ditty has more than 2 decades of experience as a highly accomplished and results-oriented quality assurance executive, with extensive global expertise in strategy development and deployment, regulatory compliance, risk management, program and project management, and audits and inspections. Prior to working in the medical device industry, quality, and regulatory, Bill served as a commissioned officer in the US Coast Guard.

Bill has years of experience in FDA inspections, quality, and regulatory compliance, including creating a regulatory compliance program and implementing a mock FDA inspection program to proactively remediate issues prior to inspection. He has implemented global quality systems from the ground up (MDSAP, EU MDR, etc.), led transition and remediation projects, and has technical working knowledge of many medical device groups, including software and connected medical devices, orthopedic, neurology, ear / nose / throat, implantables, and radiology.

John Love has 20+ years of experience in training and training development. His expertise includes both US and global regulatory standards, such as MDSAP, EU MDR, FDA QSR, and MDD (93/42/EEC).

Yogindra Dellow has two decades of experience in the life sciences field. She is well versed in medical device and pharmaceutical laws and regulations/standards, including FDA 21 CFR 820, 806, and 803; MDSAP; EU MDD/MDR; EU IVDD/IVDR; ISO 13485; and ISO 9001. Her expertise also includes quality management systems, auditing, CAPA, complaint handling, process validation, document control, supplier management, and postmarket surveillance activities.

For Oriel STAT A MATRIX, Yogindra has supported a wide range of medical device manufacturers to understand both the new EU Medical Device Regulation and the EU In Vitro Diagnostics Regulation. Yogindra has also played an integral role in developing the Oriel STAT A MATRIX IVDR training course.

Carolyn brings more than 30 years of quality system consulting, development, and management; quality system auditing; and quality engineering experience to each customer engagement.

Carolyn has worked with a wide range of medical device and pharmaceutical manufacturers to create, remediate, and optimize their QMS processes to meet the requirements of FDA regulations, EU MDR/IVDR, ISO 13485, ISO 9001, and other key international regulations and standards. In addition, Carolyn uses her expertise in quality systems training and auditing to help clients effectively implement their QMS processes, review them through internal audit programs, and present and defend them in inspections and audits.

Mariceles Mendoza brings nearly three decades of expertise to the global medical device industry. She is exceptionally knowledgeable in Quality Assurance, Regulatory Compliance, Regulatory Affairs, and Operations, with a strong background in guiding companies through market entry while adhering to FDA, CE, and international standards.

Mariceles is recognized for her mastery of design controls and risk management, providing crucial support to R&D teams. Her deep understanding of regulations and standards, including FDA, EU MDR, MDSAP, ISO 13485, and ISO 14971, has been instrumental in leading organizations through major regulatory shifts and establishing robust Quality Management Systems (QMS). She also excels in conducting audits and providing customized training to ensure inspection readiness, with a proven track record of successfully addressing FDA 483 observations and warning letters.

As Senior Director of QMS at Eliquent Life Sciences, Kimberly McCoy offers strategic guidance to medical device companies in Regulatory Affairs, Compliance, and Quality. Her extensive experience, spanning over 25 years in the medical device sector, covers a wide range of devices including wound care, orthopedics, SaMD, SiMD, and IVDs/LDTs.

Kimberly's background encompasses product development, RA/QA, clinical affairs, auditing, and training. Notably, she managed the medical device business for a major Notified Body, overseeing over 400 global auditors and technical reviewers with a P&L responsibility exceeding $100 million. Kimberly holds a RAC certification, is a former Chair for the ASQ Medical Device Division, and currently serves as a community member on an IRB. She is fluent in both English and German.